相关实验视频
Updated: Jul 8, 2026

07:48
Engineering a Bilayered Hydrogel to Control ASC Differentiation
Published on: May 25, 2012
14.0K
一种具有机械活性和生物活性的异质水凝贴片,用于慢性糖尿病伤口愈合
Suyang Dai1, Lingchen Mao1, Xiongwei Chen1
1State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Biomaterials
|July 3, 2025
概括
这项研究提出了一种用于糖尿病伤口的新型水凝贴片. 该贴片使用近红外光来收缩,减少炎症和抗击感染,促进更快的愈合.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 伤口愈合 治愈 伤口愈合
背景情况:
- 糖尿病慢性伤口由于炎症,感染风险和收缩不良而表现出延迟愈合.
- 有效的治疗需要解决这些多方面的挑战的策略.
研究的目的:
- 开发一种新的异质水凝贴片用于糖尿病伤口治疗.
- 为了研究贴片的光热,抗菌,抗氧化和机械性能.
主要方法:
- 在多孔聚氨泡中用修饰的酸盐在烯胺的现场聚合.
- 纳入去甲基化 dealkaline lignin-Fe3+ 复合物的光热特性.
- 在体内测试以评估伤口愈合效率.
主要成果:
- 水凝贴片显示近红外光响应形状记忆和双轴收缩.
- 证实了光热抗菌特性和抗氧化活性.
- 在体内研究显示,减少炎症,增强组织重建,加快伤口愈合.
结论:
- 开发的水凝贴片提供了一种双重作用的方法,结合了机械调制和生物活性.
- 这一策略为治疗慢性糖尿病伤口提供了一个有希望的新途径.
相关概念视频
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Biofilms
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

